Reconèixer els elements essencials de la professió mèdica, que incloguin els principis ètics, les responsabilitats legals i l'exercici professional centrat en el pacient Desenvolupar la pràctica professional amb respecte pels altres professionals de la salut, adquirint habilitats de treball en equip Comunicar-se de manera efectiva i clara, tant oralment com per escrit, amb els pacients, els familiars, els mitjans de comunicació i altres professionals Conèixer, valorar críticament i saber utilitzar les fonts d'informació clínica i biomèdica per a obtenir, organitzar, interpretar i comunicar la informació científica i sanitària Saber utilitzar les tecnologies de la informació i la comunicació en les activitats clíniques, terapèutiques, preventives i d'investigació Tenir, en l'activitat professional, un punt de vista crític, creatiu, amb escepticisme constructiu i orientat a la recerca Garantir el coneixement adequat de la llengua anglesa, tant oral com escrita, tenint en compte les especificitats del registre mèdic per a poder comunicar-se eficaçment a la comunitat internacional científica i professional
1. Define what “neglected tropical diseases” are and their types, epidemiological situation and transmission 2. Understand differences between control, elimination, eradication of a disease and related with neglected tropical diseases 3. Describe the difference between “mass drug administration” and “case-based” approaches 4. Describe epidemiological indicators needed to monitor and evaluate interventions to control neglected tropical diseases 5. Describe main global challenges for neglected tropical diseases control in different areas (prevention, diagnostics, treatments, implementation and research) 6. Describe the interventions lead by WHO, local or regional governments or NGO in order to manage Neglected Tropical Diseases. 7. Understand the specificities of the work done by health professionals working in the field in NTD endemic areas
Tipus d’activitat Hores amb professor Hores sense professor Total Altres 1,00 0 1,00 Anàlisi / estudi de casos 2,00 0 2,00 Aprenentatge basat en problemes (PBL) 26,00 71,00 97,00 Seminaris 4,00 0 4,00 Sessió expositiva 2,00 0 2,00 Sessió participativa 2,00 0 2,00 Treball en equip 9,00 8,00 17,00 Total 46,00 79,00 125
Sustaining the drive to overcome the global impact of neglected tropical disease. Recuperat , a http://www.who.int/topics/tropical_diseases/en Catàleg Accelerating work to overcome the global impact of neglected tropical diseases. . Recuperat , a http://whqlibdoc.who.int/hq/2012/WHO_HTM_NTD_2012.1_eng.pdf Catàleg PLOS Neglected Tropical Diseases: first open-access journal devoted to the world. Recuperat , a http://www.plosntds.org Catàleg J. Adams. K. Gurney, D. Pendlebury (2012). Thomson Reuters Global Research report neglected tropical diseases.. Dins (Ed.), WHO's Publication. . Recuperat , a http://www.who.int/leishmaniasis/resources/documents/en/PepitoBDFull.pdf Hotez PJ, Savioli L, Fenwick A (2012). Neglected Tropical Diseases of the Middle East and North Africa: Review of Their. PLoS Negl Trop Dis , 6(2), 1475. Recuperat , a http://www.plosntds.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjo Catàleg Global Strategy for dengue prevention and control, 2012–2020 (2012). Dins (Ed.), WHO's Publication (, p. 1). WHO. Cameron P. S. et al. (2012). Dengue. Current concepts. Review article. N Engl J Med , 366(), 1423-32 Catàleg Lang, Jean. (2012). Development of Sanofi Pasteur tetravalent dengue vaccine. Rev. Inst. Med. Trop. Sao Paulo, 54(18), 15-17 Catàleg Handbook for clinical management of dengue” WHO and Special Programme for Resear. Recuperat , a http://www.who.int/denguecontrol/9789241504713/en/index.html Simarro PP, Diarra A, Ruiz Postigo JA, Franco JR, Jannin JG (2011). The Human African Trypanosomiasis Control and Surveillance Programme of the Worl. PLoS Negl Trop Dis ,, Catàleg Ruiz-Postigo JA, Franco JR, Lado M, Simarro PP (2012). Human African Trypanosomiasis in South Sudan: How Can We Prevent a New Epidemic?. PLoS Negl Trop Dis ,, Catàleg WHO meeting on elimination of human African trypanosomiasis (Trypanosoma brucei . Recuperat , a http://apps.who.int/iris/bitstream/10665/79689/1/WHO_HTM_NTD_IDM_2013.4_eng.pdf Simarro PP, Franco J, Diarra A, Postigo JA, Jannin J (2012). Update on field use of the available drugs for the chemotherapy of human African. Parasitology, 139(7), 842 Catàleg Mitashi P, Hasker E, Lejon V, Kande V, Muyembe JJ, Lutumba P, Boelaert M (2012). Human african trypanosomiasis diagnosis in first-line health services of endemic. PLoS Negl Trop Dis , 6(11), Catàleg WHO Technical Report Series on the control of the leishmaniases - TRS N°949. Recuperat , a http://apps.who.int/iris/bitstream/10665/44412/1/WHO_TRS_949_eng.pdf Catàleg Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, et al. (2012). Leishmaniasis Worldwide and Global Estimates of Its Incidence. . PloS One, 7(5), 35671 Catàleg (2007). Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?. Nature reviews & Microbiology , 5(873), Catàleg Report of the Fifth Consultative Meeting on Leishmania/HIV Coinfection. Addis Ab. Recuperat , a http://www.who.int/leishmaniasis/resources/Leishmaniasis_hiv_coinfection5.pdf Bern C, Courtenay O, Alvar J (2010). Of Cattle, Sand Flies and Men: A Systematic Review of Risk Factor Analyses for S. PLoS Negl Trop Dis , 4(2), 599 Catàleg Stauch A, Sarkar RR, Picado A, Ostyn B, Sundar S, Rijal S, Boelaert M, Dujardin (2011). Visceral leishmaniasis in the Indian subcontinent: modelling epidemiology and co. PLoS Negl Trop Dis , 5(11), Pepito y la leishmaniasis. (1999). . Recuperat , a http://www.who.int/leishmaniasis/resources/documents/en/PepitoBDFull.pdf WHO (2015). INVESTING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES (3rd). WHO. INVESTING TO OVERCOME THE GLOBAL IMPACT OF NTD. 3rd NTD repost (2015). Recuperat , a http://apps.who.int/iris/bitstream/10665/152781/1/9789241564861_eng.pdf?ua=1 (2014). Local transmission of Schistosoma haematobium in Corsica, France. ECDC,, . Recuperat , a http://ecdc.europa.eu/en/publications/Publications/schistosoma-haematobium-risk-
Activitats d'avaluació: Descripció de l'activitat Avaluació de l'activitat % PBL sessions (3 case scenarios) Learning Abilities (25%) Communication (25%) Responsibility (25%) Interpersonal Relationships (25%) 50 Group activity Accreditation of knowledge acquired by means of a witten report focused on one of the objectives or one of the NTD. Groups must be formed by 2 or 3 people. Written report must be of maximum 3000 words. The written report will be 50% of the final qualification. The oral presentation will also be 50% of the final qualification. Oral presentation will be video recordered 30 PBL Exam The exam will be a standard PBL exam 20
Evaluation has 3 parts (PBL sessions, PBL exam and group activity) and both of them must be passed independently. In case PBL exam or group activity are failed, there will be a second opportunity to do them, but with a maximum score of 5 points. - PBL sessions evaluation will account for 50% of the module evaluation. Criteria (Grade proportion) Responsibility (25%) Learning abilities (25%) Communication (25%) Interpersonal relationships (25%) - The group activity with oral (video recorded) and written presentation will account for 30%. - PBL exam will account for 20%. Attendance to the Workshops and Seminars must be higher than 80% Criteris específics de la nota «No Presentat»:Not attending PBL sessions Not attending workshops (more than 20%) because of a non justified reason. Not participating in the activity group
More than 1 billion people – a sixth of the world’s population – suffer from one or more neglected tropical diseases. These diseases represent about 17% of the global burden of parasitic and infectious diseases. Most neglected tropical diseases are endemic in rural areas of sub-Saharan Africa and in poor urban settings of low-income countries in Asia and Latin America. They lead to long-term disability, disfigurement, impaired childhood growth, adverse pregnancy outcomes and reduced economic productivity. Neglected tropical diseases kill an estimated 534.000 people worldwide every year. Their impact on worker productivity adds up to billions of dollars lost annually and maintains low-income countries in poverty. Addressing neglected tropical diseases from a public health perspective often involve negotiations not only on what we want (our interests), but also on core beliefs about public health needs and priorities, and the way government and society should be working to respond to those needs and priorities (our values). Negotiations involving value conflicts are often more challenging to resolve than negotiations based primarily on interests, because negotiators may be reluctant to trade off their principles for the sake of their interests. This elective provides the opportunity to learn the current global situation of neglected tropical diseases, how large-scale interventions for control are organized and main challenges for implementation and sustainability of control.